Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-25 @ 3:07 AM
Ignite Modification Date:
2025-12-26 @ 1:47 AM
NCT ID:
NCT04948333
Group ID:
EG000
Title:
Asciminib 40 mg b.i.d. - Subjects Without MMR at Baseline
Description:
Asciminib 40 mg b.i.d. - Subjects without MMR at baseline: Participants will be treated with 80 mg of ABL001 (40 mg BID). In patients not achieving MMR at 48 weeks or losing the response after the week 48 assessment up to week 108, asciminib dose may be escalated to 200 mg q.d. if in the investigator's opinion the patient may benefit from the escalation.
Deaths Number Affected:
0
Deaths Number At Risk:
None
Serious Number Affected:
9
Serious Number At Risk:
84
Other Number Affected:
67
Other Number At Risk:
84
Study:
NCT04948333
Results Section:
NCT04948333
Adverse Events Module:
NCT04948333